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reduce blood loss in various settings. Data on their efﬁcacy are limited in gynecological hysteroscopy.
This study was conducted to compare the effect of oxytocin versus tranexamic acid on hematological
proﬁle and transfusion requirement during hysteroscopic myomectomy (HM).
Methods: Fiftywomen scheduled forHMwere randomly assigned into twogroups. Ttranexamic acid
(TXA) or oxytocin (OXY). TXA was injected with 15 mg kg1 of tranexamic acid, followed by infu-
sion of 10 mg kg1 h1. In OXY, 10 Unites of oxytocin were added to 500 mL saline (400 mU/min)
during surgery. Spinal anesthesia was induced for all patients. Hemodynamics, hematological data,
number of transfusions, serum sodium and central venous pressure were measured.
Results: TXA showed signiﬁcant decrease of heart rate 30 and 45 min and 1 and 2 h
when compared with OXY. Post operative Hb and Hct showed signiﬁcant decrease (p<
0.001) in TXA compared with OXY. CVP in TXA displayed signiﬁcant increase (p< 0.001)1001637298.
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126 S.A. Mousa et al.15 min after spinal blockade and 30 min, 45 min, 1 h and 2 h. Serum sodium showed signiﬁcant
decrease in TXA (p< 0.001) compared with OXY nearly throughout study period.
Conclusion: Use of oxytocin during HM was accompanied with stable hemodynamics, hemato-
logical proﬁle and less transfusion requirement compared with the use of tranexamic acid.
ª 2011 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Women undergoing HM are prone to signiﬁcant blood loss,
hemodynamic and hematological derangement from distention
ﬂuid medium used.
HM using the electro surgery or the Nd YAG laser may be
performed in cases of type one submucous ﬁbroids, those
greatest diameter is inside the uterine cavity [1–4].
Hysteroscopy is a routine procedure for diagnosis and
treatment of abnormal uterine bleeding and infertility assess-
ment [5,6]. Jansen et al. described an overall risk for hysteros-
copy of 0.28% and a risk for HM of 0.75% [7]. However, it
can result in potentially severe and life threatening complica-
tions as reported in some case [8].
Nonconductive and hypotonic ﬂuids such as 5% manni-
tol, 3% sorbitol, and 1.5% glycine improve visualization
during HM when bleeding occurs, and they can be used in
diagnostic as well as operative hysteroscopic media [9]. In
the last two decades, multiple researches had been promoted
on hysteroscopic procedures due to its brief hospital stay,
reduced discomfort, low costs and satisfactory short-term
results [10].
HM is a challenging surgical procedure for gynecologists
and anesthetists, which can result in signiﬁcant blood loss.
Decreasing blood loss and transfusion requirements should
improve patient safety, enhance rapid postoperative recovery,
and decrease hospital costs.
Tranexamic acid is a synthetic derivative of the amino acid
lysine that exerts antiﬁbrinolytic effect through the reversible
blockade of the lysine binding sites on plasminogen molecules
[11]. Intravenous administration of tranexamic acid has been
routinely used for many years to reduce hemorrhage during
and after surgical procedures like coronary artery bypass, sco-
liosis surgery, oral surgery, orthotopic liver transplantation,
total hip or knee arthroplasty, and urinary tract surgery
[12,13].
Tranexamic acid acts within 2–3 h after oral administration
and immediately after intravenous administration, and its half-
life is 2–10 h [14].
Oxytocin used to help start or strengthen labor and to re-
duce bleeding after delivery. Intravenous oxytocin has a very
short half-life (4–10 min). Therefore, the potential advantage
of an oxytocin infusion at hystroscopic myomectomy is that
it maintains uterine contractility throughout the surgical pro-
cedure [15].
Although oxytocin is considered to be a safe drug, it can
cause tachycardia and hypotension, and it has negative inotro-
pic, antiplatelet, and antidiuretic effects [16].
To the best of our knowledge, this is the ﬁrst prospective
randomized study designed to compare oxytocin with tranex-
amic acide as regard their effect on hemodynamics, hematolog-
ical proﬁle and intra operative transfusion requirement during
hysteroscopic myomectomy.2. Patients and methods
This prospective double blind randomized study consisted of
50 women (age range 25–45 years) with symptomatic uterine
submucous ﬁbroids scheduled to undergo hysteroscopic myo-
mectomy (HM) performed by one of the authors (Sadek ES)
at Mansoura University Hospital, out of them, 47 patients
completed the study. The indications for HM in these patients
included infertility, menorrhagia and pressure symptoms.
Exclusions criteria included patients with bleeding or coag-
ulation disorders, diabetes mellitus, cardiac disease with evi-
dent ischemia, history of myocardial infarctions and
congestive heart failure, renal insufﬁciency as well as any con-
traindication to spinal anesthesia.
The study was conducted after approval by the local ethical
committee of Department of Anaesthesia and Surgical Inten-
sive Care, Faculty of Medicine, Mansoura University. Ran-
domization was done through allocation ratio computer-
generated, random number table was used, and the results
were kept in sealed envelopes. Envelops were picked to allocate
the enrolled patients into two groups, tranexamic acid group
(TXA) and oxytocin group (Oxy), each comprised 25 patients.
A physician outside the operating team was responsible for the
preparation of the blinded injection syringes, randomized the
patients appropriately as well as enrolled the patients and as-
signed them to their respective groups.
All patients have given a written informed consent prior to
enrollment.
The day before surgery all patients were evaluated fulﬁlling
full medical history, clinical examination and ECG. Labora-
tory investigations included complete blood picture and
hematocrit, serum creatinine, serum sodium level, serum bili-
rubin, albumin, SGOT, SGPT, prothrombin time and partial
thromboplastin time and blood glucose.
The day of surgery and after arrival to the operating theater
a wide bore intravenous cannula (18 G) were inserted through
suitable peripheral veins and I.V. midazolam 0.05 mg/kg was
given. Preanesthetic monitoring included heart rate, ECG,
blood pressure (non-invasive), and peripheral oxygen satura-
tion using Drager (Inﬁnity Kappa, Mexico) monitor with Sam-
sung screen.
Five-hundred milliliter Ringer’s solution was infused to all
patients as a pre loading 1 h before induction of spinal anes-
thesia. Spinal anesthesia was performed in sitting position
using 2.5 ml 0.5% hyperbaric bupivacaine mixed with fentanyl
20 lg intrathecally after local Lidocaine 2% inﬁltration. Any
hypotension, was treated by intravenous injecting of ephedrine
5–10 mg. Hypotension deﬁned as 20% decrease in blood pres-
sure from pre-induction level or a systolic blood pressure lower
than 100 mm Hg. Surgeon was allowed to start surgery when
adequate sensory block to T10 at the umbilical level was
achieved and surgical procedure was performed by the same
surgeon for all patients.
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surgery to judge the status of the intravascular volume and
trans-compartmental ﬂuid shift using a single lumen catheter
(Amecath, France) that inserted in the right internal jugular
vein with strict sterile technique using Sildenger technique after
local inﬁltration of Lidocaine 2%. The catheter was then
ﬂushed with heparinized normal saline solution and connected
to a pressure transducer for central venous pressure monitor-
ing. The position of the catheter was conﬁrmed by antero-pos-
terior chest X-ray just after insertion by C-arm.
Patients in the TXA group were given 15 mg/kg of tranex-
amic acid (Cyklokapron@; Amoun Pharmaceutical Co., SAE)
slowly intravenously 30 min before surgery followed by 10 mg/
kg/h infusion in 500 ml Ringer’s by infusion pump till the end
of the procedure. An equal volume of normal saline syringe in
a double blinded manner was intravenously administered to
the OXY group 30 min before surgery followed by one am-
poule of oxytocin (10 U/mL/amp) (Syntocinon@; Aventis
Pharmaceutical Co.) was added to 500 mL Ringer’s solution
running at a rate of 400 mU/min by infusion pump till the
end of the procedure.
After establishing spinal anaesthesia, resection was carried
out under the use of Glycine (1.5%) as a ﬂuid distention med-
ia. Resectoscope (26 Fr) (Karl Storz) with a 24 Fr cutting loop
under videoscopic screening was used for surgical resection.
The ﬂow and the distention pressure were regulated using a
Hys-surgimat. The ﬂow rate was kept at 250–400 ml/min with
distention pressure was kept between 80 and 100 mm Hg to
maintain good visualization. The height of the irrigating ﬂuid
reservoir is ﬁxed at 60 cm height from the surgical table. The
resected tissues were collected at the end of surgery and
weighted. Histopathological examination was carried out for
a specimen from the resected tissues.
An accurate method to calculate the actual amount of
blood loss during hysteroscopic procedures that use a disten-
tion medium was very difﬁcult, so we depend on both hemody-
namics (HR and MBP) and pre operative and post operative
hemoglobin and hematocrit concentration to assess the blood
loss during this study.
Heart rate (HR), ECG monitoring, non–invasive mean
blood pressure (MBP), arterial oxygen saturation (SaO2; using
pulse oxymetry) and central venous pressure (CVP) were
recorded.
The above mentioned parameters were recorded immedi-
ately after arrival to the pre anaesthetic room (Basal or preop-
erative reading), 15 min after spinal blockade, 30 min, 45 min,
1 h, 2 h from the start of resection and 8, 16 and 24 h from the
end of the procedure using Drager (Inﬁnity Kappa, Mexico)
monitor with Samsung screen.
Hb, Hct, PT and PTT (using Automatic Cell Counter; Sys-
mex Kx-21, Japan) were measured preoperatively and immedi-
ately postoperative. Serum sodium concentration was
measured at preoperative (basal), 15 min after spinal blockade,
30 min, 45 min, 1 h, 2 h from the start of resection and 8, 16
and 24 h from the end of the procedure.
The amount of distension ﬂuid medium used in each patient
is calculated. The total amount of urine output was calculated
by indwelling Foley’s catheter, that was inserted to all patients
after the spinal blockade. Any complications were noted at the
end of the study.
The power of this clinical trial was retrospectively calcu-
lated using the G Power analysis program version 3 [17]. Usingpost-hoc power analysis with accuracy mode calculations with
hemoglobin concentration as the primary variant and assum-
ing type-I error protection of 0.05 and an effect size convention
of 0.8, a total sample size of 50 patients produced a power of
0.87.
The statistical analysis of data done by using excel program
for ﬁgures and SPSS (SPSS, Inc, Chicago, IL) program statis-
tical package for social science version 16. To test the normal-
ity of data distribution K–S (Kolmogorov–Smirnov) test was
done only signiﬁcant data revealed to be nonparametric.
N.B: all tested data revealed to be parametric. The description
of the data done in form of mean (±) SD for quantitative data
and frequency and proportion for qualitative data.
The analysis of the data was done to test statistical signiﬁ-
cant difference between groups.
Chi square test was used for qualitative data. Any differ-
ence or change showing probability (P) less than 0.05 was con-
sidered statistically signiﬁcant at conﬁdence interval 95%.3. Results
The ﬂow diagram of participation in this study is shown in
Fig. 1. Two patients of TAX Group (one had a severe hemor-
rhage requiring vasopressor and blood transfusion; one failed
blinding) and one of OXY Group (exposed to un blinding)
were excluded from the analysis of the study outcomes. In this
study, there were no signiﬁcant differences between TAX
group and OXY group with respect to age (25–45 and 26–
44 years, respectively), weight (55–88 and 58–82 kg, respec-
tively), and body mass index BMI (20.7–33.3 and 20.5–32.0,
respectively). All patients were ASA I and II (ASA I/ASA
II = 13/10 and 13/11, respectively). The duration of surgery
and the weight of resected tissues also showed no signiﬁcant
intergroup differences (Table 1).
The used distention ﬂuid medium (glycine 1.5%) displayed
no signiﬁcant difference between the studied groups
(5195 ± 1855 ml) in TXA group versus (4975 ± 985 ml) in
OXY group with p value 0.38 (Table 1).
The total amount of the urine output, at the end of the pro-
cedure reﬂected no difference between the studied groups
(465.20 ± 127.58) in TXA group versus (468.80 ± 82.43) in
OXY group with a p value 0.91, and no patients taken diuretic
therapy (Table 1).
Heart rate demonstrated a signiﬁcant decrease in TXA
group compared with OXY group nearly throughout the study
period (p ranged from <0.01 to <0.001) (Table 2).
Mean arterial blood pressure (MBP) showed a signiﬁcant
decrease (p< 0.02) in TXA group compared with OXY group
15 min after spinal blockade (Table 2).
Peripheral arterial oxygen saturation (SPO2) was signiﬁ-
cantly increased in TXA group (p< 0.03) compared with
OXY group at 8, 16 and 24 h from the end of the procedure
(Table 2).
Both the pre operative hemoglobin (Hb) and hematocrit
(Hct) concentration were comparable to each other in both
groups. Post operative Hb concentration displayed signiﬁcant
decrease (p< 0.001) in TXA group compared with oxy group.
Also, Hct level showed signiﬁcant decrease in TXA group
compared with the OXY group (p< 0.001) (Table 3).
Both pre operative and post operative prothrombine time
(PT) and partial thromboplastine time (PTT) were comparable
Assessed for eligibility (n=70) 
Excluded (n=20) 
Not meeting inclusion criteria (n=8) 
Refused to participate (n=12) 
Randomized (n=50) 
Allocated to TXA group (n=25) Allocated to OXY group (n=25) 
Excluded (n=2) 
Protocol Violation: 
Case 5: Sever hemorrhage  
requiring vasopressor and 
blood transfusion 
Case 22: Un blinding    
Excluded (n=1) 
Protocol Violation : 
Case 11: Un blinding 
Analyzed (n=23) Analyzed (n=24) 
Figure 1 Patients ﬂow diagram.
Table 1 Patients characteristics and duration of surgery (min) of the studied groups. Values are presented as mean ± SD, (number)
and (%) for ASA classiﬁcation.
TXA group (N= 23) OXY group (N= 24) p Value
N % N %
ASA
I 13 56.5 13 54 0.76
II 10 43.5 11 46
Age (ys) 34.08 ± 6.43 35.24 ± 5.17 0.48
Wt (kg) 68.52 ± 7.13 70.36 ± 6.26 0.33
BMI 26.27 ± 3.28 26.21 ± 2.99 0.94
Duration of surgery (min) 61.24 ± 15.97 61.48 ± 14.47 0.95
Resected Tissues (gm) 179.36 ± 23.77 183.44 ± 27.00 0.57
Total glycine used (ml) 5195 ± 1855 4975 ± 985 0.38
Total urine output (ml) 465.20 ± 127.58 468.80 ± 82.43 0.91
TXA= tranexamic acid and OXY= oxytocin.
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Table 2 Hemodynamic data: heart rate (HR, bpm), mean arterial blood pressure (MBP, mm Hg), and peripheral arterial oxygen
saturation (SPO2, %) of the studied groups. Values are presented as mean ± SD.
TXA group (N= 23) OXY group (N= 24)
HR MBP SPO2 HR MBP SPO2
Preop 89.28 ± 12.9 126.28 ± 11.48 98.72 ± 1.24 88.72 ± 14.75 131.40 ± 11.54 98.12 ± 1.33
15 min After spinal block 90.56 ± 8.76 104.76 ± 8.81* 99.00 ± 0.82 94.16 ± 14.49 107.96 ± 10.86 99.20 ± 0.82
30 min From start of resection 92.56 ± 7.16* 104.52 ± 6.58 99.56 ± 0.58 102.16 ± 10.71 108.92 ± 6.73 99.68 ± 0.48
45 min From start of resection 94 ± 6.48* 113.16 ± 8.17 100.04 ± 2.13 101.6 ± 9.26 115.52 ± 6.78 99.76 ± 0.44
1 h From Start of resection 93.52 ± 6.31* 127.84 ± 10.47 99.72 ± 0.46 99.04 ± 8.07 125.80 ± 7.21 99.64 ± 0.57
2 h From Start of resection 92.72 ± 5.56* 126.40 ± 6.20 98.36 ± 0.91 96.56 ± 7.024 128.48 ± 6.14 98.36 ± 1.04
8 h 90.28 ± 5.69* 128.16 ± 5.12 98.12 ± 0.78* 93.6 ± 6.15 127.84 ± 5.84 97.64 ± 0.70
16 h 88.72 ± 5.71 126.92 ± 5.80 99.32 ± 0.69* 91.88 ± 5.86 127.28 ± 6.52 98.44 ± 1.00
24 h 87.56 ± 6.48* 127.40 ± 5.69 99.52 ± 0.59* 91.2 ± 5.62 129.12 ± 7.02 98.88 ± 1.05
TXA= tranexamic acid and OXY= oxytocin.
p Is signiﬁcant if <0.05.
* Signiﬁcant difference with the same value in the other group.
Table 3 Hematological data: Hemoglobin (Hb, g/dL) and Hematocirt (Hct, %) and Prothrombine time (PT, s), Partial
thromboplastine time (PTT, s) and Patients who underwent transfusion of the studied groups. Values are presented as mean ± SD and
number (percentage).
TXA group (N= 23) OXY group (N= 24) p Values
Preoperative
Preop Hb 11.95 ± 0.78 11.81 ± 0.74 0.51
Preop Hct 39.76 ± 2.20 39.80 ± 2.33 0.95
Preop PT 11.84 ± 0.90 11.80 ± 0.71 0.86
Preop PTT 29.56 ± 2.86 29.68 ± 1.93 0.86
Postoperative
Post op Hb 10.18 ± 0.62* 11.13 ± 0.70 <0.001
Post op Hct 32.68 ± 2.41* 38.16 ± 1.86 <0.001
Post op PT 12.12 ± 0.73 12.12 ± 0.53 1.00
Post op PTT 29.80 ± 2.38 30.12 ± 1.59 0.58
Patients who underwent transfusion 5 (21.7%) 1 (4.1%) 0.09
TXA= tranexamic acid and OXY= oxytocin.
p Is signiﬁcant if <0.05.
Data are given as number (percentage) of each group.
* Signiﬁcant difference with the same value in the other group.
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the groups (Table 3).
Also, the number of patients whose underwent RBCs trans-
fusion displayed no signiﬁcant difference between the two
groups. Five patients in TXA group (21.7% of the total num-
ber of the group) and one patient in OXY group (4.1% of the
total number of the group) underwent RBCs transfusion
(Table 3).
Regarding central venous pressure in TXA group revealed
a highly signiﬁcant increase (p< 0.001) at 15 min after spinal
blockade and at 30 min, 45 min, 1 h and 2 h from the start of
resection (Fig. 2).
Sodium level concentration showed a highly signiﬁcant de-
crease in TXA group (p< 0.001) compared with OXY group
nearly throughout the study period (Fig. 3).
4. Discussion
In the present study, oxytocin and tranexamic acid were com-
pared as regard their effect on hematological proﬁle and theirability to decrease the need for blood transfusion during HM.
Patients in both groups demonstrated a comparable demo-
graphic characteristics. This clinical study showed that the
use of oxytocin during HM resulted in stable hematological
parameters (Hb, Hct, PT and PTT) and signiﬁcant decrease
of Hb and Hct concentration with the use of tranexamic acid
in comparable to oxytocin. In addition, only one patient re-
quired blood transfusion in OXY group. Oxytocin was associ-
ated with signiﬁcant increase in HR compared with tranexamic
acid with nearly comparable MBP and SPO2. One of the con-
siderable results of this study, was the protective effect of oxy-
tocin against absorption of distension ﬂuid medium during
HM, that proved by the signiﬁcant increase in central venous
pressure as well as signiﬁcant decrease in serum sodium con-
centration in TXA group compared with OXY group.
Most of the surgical procedures consuming a distention
ﬂuid medium to provide a good visualization were accompa-
nied with a serious complication of ﬂuid absorption and sever
bleeding [18]. Hence, our interest in this study was to compare
the efﬁcacy of oxytocin and tranexamic acid as regard the
Figure 3 Serum sodium concentration (Na+) (meq/L) of the studied groups, black column ( ) (OXY) n= 24 and white column (h)
(TXA) n= 23.
Figure 2 Central venous pressure (CVP) (mm Hg) of the studied groups, white column (h) (TXA) n= 23 and black column ( ) (OXY)
n= 24.
130 S.A. Mousa et al.maintenance of the hemodynamics and hematological proﬁle
within the physiological range.
As regard hemodynamic changes, a lot of studies have been
proved that there were many causes to the maternal hemody-
namic alteration during delivery, including uterine contraction,
stress factor, relieve of the aorto-caval compression and blood
loss, but many studies consider the uterotonic drugs (oxytocin)
have a dominant effect [19,20].
This study showed that, heart rate was signiﬁcantly reduced
in tranexamic acid group than oxytocin group nearly at all
time of the study period. But with highly signiﬁcance
(p< 0.001) observed at 30 and 45 min from the start of resec-
tion, most probably due to the actual increase of heart rate
that might be occur with the oxytocin group at these time of
readings. This result was in accordance with the previous study[21] which state that an intravenous bolus ﬁve unites of oxyto-
cin injected in pregnant women undergoing an elective caesar-
ean section under spinal anaesthesia produced an elevation of
heart rate from 85 to 119 with a p value <0.003. Another
study [22] compared oxytocin given either by bolus or infusion,
proved a signiﬁcant increase in heart rate which is so rapid
within (30 s) with bolus injection but with steady manner of in-
crease by infusion.
Regarding mean arterial blood pressure (MBP), it was
showed signiﬁcant decrease with tranexamic acid group
(p< 0.02) compared with the oxytocin group at 15 min after
spinal blockade. Which could be attributed to the effect of
spinal blockade, that needed to be treated with ephedrine
and ﬂuid therapy. However, this decrease was not continue
and restricted only at this time of the study.
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crit (Hct) values (p< 0.001) in the post operative period in
TXA group compared with the OXY group, we believe, is a re-
sult of the uterotonic effect of oxytocin which might be more
effective in reducing surgical blood loss than the anti ﬁbrino-
lytic effect of tranexamic acid. Another explanation for signif-
icant decrease in Hb and Hct values in TXA group could be
explained by the dilutional effect of the absorbed irrigate ﬂuid,
especially when this result was supported by the signiﬁcant in-
crease in central venous pressure (CVP) (p< 0.001) which oc-
curs at the same time of the study period in TXA group. This
signiﬁcant increase in CVP with TXA group compared with
the OXY group, caused by the possibility of absorption of sig-
niﬁcant amount of irrigating ﬂuid, make the oxytocin an ideal
uterotonic drug used during HM decrease the problem of ﬂuid
over load. This result was in accordance with the result of the
previous study that used oxytocin drip during hysteroscopic
myomectomy [23]. However, the signiﬁcant increase in CVP
in TXA group was within the physiological ranges.
Dilutional effect of ﬂuid absorption on Hb and Hct values
are in a agreement with previous ﬁndings, that in surgical pa-
tients, low Hct and Hb together with elevated CVP are usually
encountered as a result of excess ﬂuid absorption [24]. On the
other hand, our results are contradictory to the previous stud-
ies, those proved signiﬁcant increase of Hb and Hct when tran-
examic acid used versus placebo to reduce intra operative
blood loss and transfusion requirement [25–27].
Preoperative and post operative prothrombine time (PT)
and partial thromboplastine time (PTT) were comparable in
both group, indicating that tranexamic acid and oxytocin have
no draw back on the coagulation pathway in the current study.
This is in agreement with the previous ﬁndings that showed no
signiﬁcant changes, both in the preoperative as well as the post
operative values of PT and PTT when tranexamic acid was
used versus placebo in pediatric craniosynostosis surgery
[27]. Similarly, another study carried out in total knee arthro-
plasty proved the same results [28].
In this study ﬁve patients need RBCs transfusion during
surgery (one unit for each patient) in the TXA group, where
as only one patient required one unite RBCs transfusion in
OXY group. So, it was no signiﬁcant difference between both
group in the issue of the blood transfusion. Previous study was
in agreement with our result, when it used tranexamic acid ver-
sus placebo to decrease the total number of transfusion unites
during total hip replacement surgery [25]. On the other hand,
different studies were demonstrated a signiﬁcant decrease
(p< 0.001) in the number of the transfused RBCs unites when
used tranexamic acid to decrease blood loss and transfusions
during total knee arthroplasty [25].
As regard sodium level concentration, it showed highly sig-
niﬁcant decrease (p< 0.001) in TXA group compared with
OXY group, which could be explained with the dilutional ef-
fect of the irrigate ﬂuid absorption, however, it did not accom-
panied with any symptoms related to ﬂuid over load (nausea,
vomiting, irritability, etc.), neither it need any diuretic therapy.
This result was in accordance with a previous study [18] that
proved signiﬁcant decrease in serum sodium concentration in
40 out of 46 patients underwent transcervical resection of the
endometrium using 1.5% glycine as an irrigating solution.
Youn et al (2011) [9], in his case report, demonstrated extreme
hyponatremia with moderate acidosis during hysteroscopicmyomectomy as a result of excess absorption of ﬂuid disten-
tion media.
This current study had certain limitations, includes inability
to accurately measure the actual blood loss. Also we could not
use a different dose of the drugs (especially tranexamic acid) so
the efﬁcacy of the drug and the severity of bleeding were varied
which might have its effect on the total blood loss and total
transfusion requirement. Other limitations includes, no drug
combination groups were used. We recommend further and
continuous investigations to reach to the best regimen that
could has an effective haemostatic effect in such procedures.
5. Conclusion
Maintaining physiological hemodynamics and hematological
proﬁle are crucial in most of all surgeries. According to the
measured variables with the positive and negative ﬁndings of
the studied drugs, we can conclude that, oxytocin is more
effective in reducing the transfusion requirement than tranex-
amic acid in the current study with more stable hematological
and hemodynamic proﬁle. Future studies in this ﬁeld should
continue, trying to exclude limitations and drawbacks of this
study through use of different doses of tranexamic acid as well
as including drug combination group.
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